# A Study to Assess the Safety and Tolerability of SSS11 in Healthy Subjects.

> **NCT03388515** · PHASE1 · UNKNOWN · sponsor: **Shenyang Sunshine Pharmaceutical Co., LTD.** · enrollment: 40 (estimated)

## Conditions studied

- Gout

## Interventions

- **BIOLOGICAL:** SSS11
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT03388515
- **Lead sponsor:** Shenyang Sunshine Pharmaceutical Co., LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-10-09
- **Primary completion:** 2019-07-30
- **Final completion:** 2020-01-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2018-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03388515

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03388515, "A Study to Assess the Safety and Tolerability of SSS11 in Healthy Subjects.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03388515. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*